Novo Nordisk A/S
NVO | NYSE
$40.00
+$0.86 (+2.20%)
At close: Oct 30, 2026, 4:00 PM ET
$39.88
-$0.12 (-0.30%)
Pre-market:
Nov 2, 2026, 8:05 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 20.99B | 48.56B | 26.89B | 20.01B | 26.5B | 29.03B | 28.23B | 27.3B | 20.05B | 25.41B | 21.96B | 22.48B | 19.43B | 19.81B | 13.59B | 14.41B | 13.32B | 14.21B | 10.89B | 12.12B | 12.12B | 12.62B |
Depreciation & Amortization | 10.3B | 3.54B | 5.56B | 7.76B | 4.83B | 3.83B | 5.2B | 2.15B | 8.85B | 2.91B | 2.99B | 2.53B | 2.18B | 1.72B | 1.23B | 2.04B | 1.64B | 1.65B | 1.37B | 1.35B | 1.22B | 1.38B |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.54B | n/a | n/a | n/a | 1.04B | n/a | n/a | n/a |
Other Working Capital | 13.32B | -33.23B | 20.37B | -4.96B | 4.76B | -16.43B | 13.6B | -11.26B | 9.86B | -9.61B | -9.68B | 11.67B | -4.02B | -10.22B | 7.66B | -11.01B | 4.09B | 1.89B | 153M | 293M | 2.87B | -1.13B |
Other Non-Cash Items | 4.7B | -8.39B | -52.5B | 17.79B | -2.61B | 156M | -42.06B | 18.58B | 6.47B | -10.91B | -11.38B | -1.29B | 6.16B | 13.57B | -2.23B | 15.18B | 1.44B | 2.12B | -2.48B | 4.75B | 6.26B | -4.93B |
Deferred Income Tax | 5.89B | 13.62B | 7.29B | 5.51B | 7.3B | 8B | 7.33B | 7.08B | 5.28B | 6.51B | 5.66B | 5.59B | 4.83B | 4.92B | n/a | 3.63B | 3.48B | 3.71B | n/a | 2.99B | 2.79B | 3.32B |
Change in Working Capital | 13.32B | -33.23B | 20.37B | -4.96B | 4.76B | -16.43B | 13.6B | -11.26B | 9.86B | -9.61B | -9.68B | 11.67B | -4.02B | -10.22B | -7.03B | -11.01B | 4.09B | 1.89B | -13.84B | 293M | 2.87B | -1.13B |
Operating Cash Flow | 55.2B | 24.08B | 7.62B | 46.11B | 40.79B | 24.59B | 12.3B | 43.85B | 50.5B | 14.31B | 9.55B | 40.97B | 28.58B | 29.81B | 7.1B | 24.24B | 23.96B | 23.59B | -3.02B | 21.51B | 25.26B | 11.26B |
Capital Expenditures | -12.8B | -12.04B | -43.84B | -15.42B | -16.28B | -14.59B | -16.56B | -12.5B | -13.24B | -9.01B | -16.44B | -10.62B | -7.04B | -4.8B | -4.96B | -4.23B | -2.58B | -1.78B | -2.05B | -1.69B | -1.88B | -1.5B |
Cash Acquisitions | n/a | 44M | 1B | n/a | n/a | n/a | -81.5B | n/a | n/a | n/a | n/a | n/a | n/a | 1.95B | n/a | 995M | 140M | 260M | -18.28B | n/a | n/a | n/a |
Purchase of Investments | -94M | n/a | n/a | -26M | -582M | -115M | -353M | -8.44B | -9.87B | -1.16B | -948M | -4.83B | -5.15B | -2.36B | -3.12B | -1.71B | -3.06B | -1.85B | -228M | -3.13B | -1.41B | -2.35B |
Sales Maturities Of Investments | 51M | 21M | 21M | 16M | 2.61B | 8.03B | 7.19B | 35M | 3.04B | 14.13B | 2.67B | 2.21B | 2.9B | 515M | 2.52B | 970M | 1.43B | 1.73B | 222M | 179M | 403M | 368M |
Other Investing Acitivies | -46M | -466M | -25.41B | -1.79B | -1.61B | -1.16B | -458M | -384M | -3.44B | -535M | -7.03B | -4.8B | -1.16B | -1.95B | -8.29B | -995M | -140M | -260M | -265M | -513M | -175M | -93M |
Investing Cash Flow | -12.76B | -11.71B | -42.81B | -15.43B | -14.25B | -6.67B | -91.22B | -20.9B | -20.73B | 3.96B | -14.72B | -13.24B | -9.29B | -6.65B | -13.85B | -4.96B | -4.2B | -1.91B | -20.6B | -4.64B | -2.89B | -3.48B |
Debt Repayment | -7.34B | 14.75B | 29.47B | -433M | -19.62B | 15.33B | 44.33B | -413M | 29.46B | -317M | -355M | -261M | -373M | -478M | -129M | -330M | -244M | -1.71B | 12.06B | -175M | 3.93B | -349M |
Common Stock Repurchased | -3.5B | -2.4B | n/a | n/a | n/a | -1.39B | -7.49B | -2.41B | -7.45B | -2.84B | -9.76B | -6.14B | -8.82B | -5.2B | -7.54B | -4.62B | -7.45B | -4.48B | -7.51B | -3.54B | -5.44B | -2.96B |
Dividend Paid | n/a | -35.31B | n/a | -16.66B | 174M | -35.27B | n/a | -15.58B | n/a | -28.56B | n/a | -13.43B | n/a | -18.34B | n/a | -9.61B | n/a | -15.69B | n/a | -8.02B | -1M | -13.5B |
Other Financial Acitivies | -8.29B | 5.53B | n/a | n/a | -26.78B | 26.78B | n/a | n/a | -5.33B | 5.33B | n/a | n/a | -3.39B | 3.39B | n/a | n/a | -2.74B | 2.74B | n/a | n/a | -2.33B | 2.33B |
Financial Cash Flow | -19.13B | -17.43B | 29.47B | -17.1B | -46.23B | 5.45B | 36.84B | -18.4B | 16.68B | -26.38B | -10.12B | -19.83B | -12.59B | -20.62B | -7.67B | -14.56B | -10.43B | -19.14B | 4.55B | -11.73B | -3.84B | -14.48B |
Net Cash Flow | 23.36B | -5.34B | -5.62B | 13.65B | -20.5B | 23.28B | -41.36B | 4.2B | 46.5B | -8.07B | -15.49B | 8.31B | 6.64B | 2.28B | -15.26B | 5.16B | 9.55B | 2.49B | -18.77B | 5.26B | 18.55B | -6.55B |
Free Cash Flow | 42.4B | 12.05B | -36.22B | 30.69B | 24.51B | 10.01B | -4.26B | 31.35B | 37.27B | 5.31B | -6.89B | 30.34B | 21.54B | 25.01B | 2.14B | 20.01B | 21.39B | 21.81B | -5.07B | 19.82B | 23.37B | 9.76B |
Adj. Free Cash Flow | 42.4B | 12.05B | -36.22B | 30.69B | 24.51B | 10.01B | -4.26B | 31.35B | 37.27B | 5.31B | -6.89B | 30.34B | 21.54B | 25.01B | 601M | 20.01B | 21.39B | 21.81B | -6.11B | 19.82B | 23.37B | 9.76B |
Maintenance CapEx | -10.3B | -3.54B | -43.84B | -13.84B | -12.5B | -9.12B | -9.41B | -7.97B | -8.28B | -4.69B | -11.12B | -6.68B | -3.13B | -1.41B | -2.31B | -1.52B | -339.39M | n/a | -531.29M | -537.77M | -1.14B | -1.5B |
Growth CapEx | -2.5B | -8.5B | n/a | -1.57B | -3.77B | -5.46B | -7.15B | -4.54B | -4.96B | -4.32B | -5.32B | -3.94B | -3.9B | -3.39B | -2.65B | -2.7B | -2.24B | -1.78B | -1.52B | -1.15B | -743.54M | n/a |
Owner Earnings | 44.9B | 20.55B | -36.22B | 32.26B | 28.28B | 15.47B | 2.89B | 35.88B | 42.23B | 9.63B | -1.57B | 34.28B | 25.44B | 28.41B | 4.79B | 22.72B | 23.62B | 23.59B | -3.55B | 20.97B | 24.11B | 9.76B |
Add to Watchlist
Select watchlists to add or remove NVO